Clinical Pathway Discloses One Surgeon's $425 Habit

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 6
Volume 5
Issue 6

PHILADELPHIA--When practice guidelines or pathways take financial considerations into account, they may be termed clinical financial pathways (CFPs). This technique was developed by Kent Giles, MPPM, vice president of development at PhyMatrix, a physician management company headquartered in West Palm Beach, Fla, and is currently being utilized by PhyMatrix to reduce unnecessary medical costs.

PHILADELPHIA--When practice guidelines or pathways take financialconsiderations into account, they may be termed clinical financialpathways (CFPs). This technique was developed by Kent Giles, MPPM,vice president of development at PhyMatrix, a physician managementcompany headquartered in West Palm Beach, Fla, and is currentlybeing utilized by PhyMatrix to reduce unnecessary medical costs.

Developing CFPs involves seven steps, Mr. Giles said at the Associationof Cancer Executives meeting (see also page 20): Select a diseaseprocess, form a knowledgeable team, clarify the current stateof medical knowledge, develop the pathway, assign costs to eachprocess, implement the pathway, and monitor the results.

During development of the prostate CFP, he said, the team foundthat one urologist was using three surgical trays per radicalprostatectomy to access the three instruments he needed, sincethe hospital routinely placed only one of these instruments onthe surgical tray.

This practice, which added $425 in unnecessary costs for extrasterilization and wasted anesthesiologist and surgeon time, waseliminated with implementation of the CFP, and the patient's timeunder anesthesia was reduced by 30 minutes, ie, a quality enhancement.

Recent Videos
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Related Content